The programme allows for new or existing clients to increase the time or bandwidth they use by multiples of up to 10 to meet needs as they arise. The new program is available as an on-premise, hybrid or cloud-based solution.
In recent weeks, many organisations have exponentially increased their demand for video communication platforms.
Vidyo's track record of supporting large health organisations, as well as major financial corporations, government agencies and educational institutions, positions it as an ideal solution for rapidly evolving contingency plans.
Specifically, the Vidyo Telehealth solution enables clinics and hospitals to protect front-line staff and patients by supporting self-isolation and quarantine scenarios, and ensures clinicians, nurses and physicians can provide remote diagnoses and treatments, often with existing technology.
Vidyo enriches people's lives by embedding real-time video into digital communications in the moments that matter most.
Millions of people around the world connect visually every day through Vidyo's secure, scalable technology and cloud-based services.
Its patented platform integrates with virtually any application environment, network and device to deliver the highest quality experiences that strengthen teams, build trust, solidify relationships, and improve quality of life.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system